[HTML][HTML] Emerging therapies for small cell lung cancer
S Yang, Z Zhang, Q Wang - Journal of hematology & oncology, 2019 - Springer
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
[HTML][HTML] Emerging therapies for small cell lung cancer
S Yang, Z Zhang, Q Wang - Journal of Hematology & Oncology, 2019 - ncbi.nlm.nih.gov
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
Emerging therapies for small cell lung cancer
S Yang, Z Zhang, Q Wang - Journal of Hematology & Oncology, 2019 - go.gale.com
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
Emerging therapies for small cell lung cancer
Y Sen, Z Zhang, Q Wang - Journal of Hematology & Oncology, 2019 - search.proquest.com
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
Emerging therapies for small cell lung cancer.
S Yang, Z Zhang, Q Wang - Journal of Hematology & Oncology, 2019 - europepmc.org
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
[HTML][HTML] Emerging therapies for small cell lung cancer
S Yang, Z Zhang, Q Wang - … of Hematology & …, 2019 - jhoonline.biomedcentral.com
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
[引用][C] Emerging therapies for small cell lung cancer
S Yang, Z Zhang, Q Wang - Journal of Hematology & Oncology, 2019 - cir.nii.ac.jp
Emerging therapies for small cell lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
Emerging therapies for small cell lung cancer.
S Yang, Z Zhang, Q Wang - Journal of Hematology & …, 2019 - search.ebscohost.com
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
Emerging therapies for small cell lung cancer
S Yang, Z Zhang, Q Wang - Journal of Hematology & Oncology, 2019 - infona.pl
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
Emerging therapies for small cell lung cancer
S Yang, Z Zhang, Q Wang - Journal of hematology & …, 2019 - pubmed.ncbi.nlm.nih.gov
Currently, chemotherapy remains the standard treatment for first-and second-line
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …
management of small cell lung cancer (SCLC). Immunotherapy has made progress in the …